Search results
Erowid is a non-profit educational & harm-reduction resource with 60 thousand pages of online information about psychoactive drugs, plants, chemicals, and technologies including entheogens, psychedelics, new psychoactive substances, research chemicals, stimulants, depressants and pharmaceuticals.
- Chemicals
Extensive information about psychoactive chemicals and drugs...
- All Sections
Experience : 'Still, a Psychedelic Overall', by ziomale...
- Experiences
The index into Erowid's collection of more than 45,000...
- Freedom
As nightfall does not come at once, neither does oppression....
- Culture
Information about influential or inspirational people in the...
- 2023 September Drive
Erowid received over 1150 donations in September, one of our...
- Tech
Information about technologies, devices, hardware and...
- By Substance
The full list of substances and categories covered by...
- Chemicals
The index into Erowid's collection of more than 45,000 personal reports describing first-hand experiences with psychoactive plants and drugs.
10 paź 2024 · Discover the most relevant papers, trials, events, companies, and people in our extensive collection of over 5,000 entries and 100,000 data points. Our interconnected databases allow you to uncover valuable insights and connections in psychedelic research.
24 wrz 2023 · Information about psychoactive drugs (plants, chemicals, pharmaceuticals, herbs and nootropics) including recreational, traditional, spiritual, and responsible use, dosage, chemistry, effects, experiences, images, research, legislation, media coverage, bibliographies and lots of links.
MAPS is your trusted source for evidence-based information about psychedelic substances and integrated treatments
This overview seeks to map out drug discovery & development activity in psychedelics. Drugs currently undergoing clinical trials are presented first, while drugs that are at the discovery or preclinical stage are catalogued in the latter half of this page.
30 lip 2024 · The FAQs cover a wide range of topics, including the definition and classification of psychedelic substances, their current legal status, patterns of use in Europe and ongoing clinical research.
